| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/28/2004 | CN1471392A Method for the treatment of neurological and neuropsychological disorders |
| 01/28/2004 | CN1470284A Use of vMIP and congeneric E protein ligand in pharmacy |
| 01/28/2004 | CN1470283A Method for preparing injecta of anti-hepatitis-B-virus transspecific factor |
| 01/28/2004 | CN1136230C Urogenital carcinoma TLP complex peptides and antibodies thereof |
| 01/28/2004 | CN1136229C Action of proinsulin associated peptide on dopamine transporter and its application in treating correlative diseases |
| 01/28/2004 | CN1136228C Casein phospho peptide, casein containing same and process for the preparation thereof |
| 01/28/2004 | CN1136224C Inositolglycuns having insulin-like action |
| 01/28/2004 | CN1136007C Lipid metabolism ameliorant |
| 01/28/2004 | CN1135988C Use of botulinum toxin in preparing pharmaceutical composition for treating prostatic disorders |
| 01/28/2004 | CN1135970C Use of micro particles having a protein and an antiboby absorbed theron for preparing a pharmaceutical composition for intranasal administration |
| 01/27/2004 | US6683210 Human t-cell leukemia/lymphoma virus, human immunodeficiency virus, and lymphadenopathy associated virus treatment |
| 01/27/2004 | US6683189 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 01/27/2004 | US6683172 Composition for inhibiting inflammatory response comprising at least one nucleic acid molecule selected from specified sequences |
| 01/27/2004 | US6683171 Contacting fkhsf specific nucleic acid probe under high stringency hybridizing conditions with at least one nucleic acid molecule from biological sample, detecting formation of hybrid, indicating presence of fkhsf nucleic acid molecule |
| 01/27/2004 | US6683165 Human gene relating to respiratory diseases and obesity |
| 01/27/2004 | US6683163 Monitoring angiogenesis factor |
| 01/27/2004 | US6683161 Human ependymin |
| 01/27/2004 | US6683160 Antibodies specific for Fkhsf gene products |
| 01/27/2004 | US6683158 Alpha-subunit of the Mac-1 leukocyte adhesion receptor |
| 01/27/2004 | US6683157 Variant human α7 acetylcholine receptor subunit, and methods of production and use thereof |
| 01/27/2004 | US6683155 Purified and isolated polypeptide comprising specified amino acid sequence; regulating degradation of extracellular matrix |
| 01/27/2004 | US6683080 Treatment of diabetes mellitus |
| 01/27/2004 | US6683076 Methods for therapeutic use of glucosylceramide synthesis inhibitors and composition thereof |
| 01/27/2004 | US6683062 Attaching a bioeffecting agent to a substrate with an anchor provided by a linker compound which also forms a cleavable linkage so that the drug has a sustained release; anti-thrombogenic, -imicrobial, -inflammatory agents |
| 01/27/2004 | US6683059 Constructs for suppression of oncogenic transformation, tumorigenesis and metastasis |
| 01/27/2004 | US6683058 Methods for therapy of neurodegenerative disease of the brain |
| 01/27/2004 | US6683057 Suppressing g beta gamma signaling; reducing intimal hyper-plasia following vein grafting and restenosis following arterial injury |
| 01/27/2004 | US6683056 Synergistic mixture with antilipemic agent |
| 01/27/2004 | US6683055 Guanidine or amidine termined peptides |
| 01/27/2004 | US6683054 Use of melagatran |
| 01/27/2004 | US6683053 Insulin-like growth factor agonist molecules |
| 01/27/2004 | US6683052 Lipopeptides containing an interferon-γ fragment, and uses thereof in pharmaceutical compositions |
| 01/27/2004 | US6683051 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 01/27/2004 | US6683050 Compounds with anti-KS and anti-HIV activity |
| 01/27/2004 | US6683049 Relieving pain from neuromuscular disorders using botulinum toxins |
| 01/27/2004 | US6683048 Compounds and methods for stimulating gene expression and cellular differentiation |
| 01/27/2004 | US6683047 Method of inhibiting transcription utilizing nuclear receptors |
| 01/27/2004 | US6683046 Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto |
| 01/27/2004 | US6682930 Triplex forming oligonucleotides and their use in anti-HBV |
| 01/27/2004 | US6682928 Cell is transformed to express on its surface a component which binds to an fc receptor of an effector cell used as a vehicle to increase an cell lysis and phagocytosis against an antigen associated with the cell |
| 01/27/2004 | US6682919 Polynucleotide sequence encodes the same mature polypeptide, expressed by the fabh gene contained in staphylococcus aureus |
| 01/27/2004 | US6682917 Rate-limiting enzyme, which converts ribonucleotides to their corresponding deoxyribonucleotides and supplies them for purposes of dna synthesis; drug comprising protein; kit for screening for modulators of protein activity |
| 01/27/2004 | US6682909 Polypeptide for use in the diagnosis, treatment and prevention of hepatitis infections |
| 01/27/2004 | US6682906 Cloned glutamic acid decarboxylase |
| 01/27/2004 | US6682904 Detecting a decrease in hyal2 activity due to contact with the test agent, wherein the test agent does not substantially affect activity of an anti-inflammatory hyaluronidase, thereby identifying an agent that specifically inhibits hyal2 activity |
| 01/27/2004 | US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis |
| 01/27/2004 | US6682901 Detecting cancer in humans; obtain cells, incubate with cadherins, monitor binding |
| 01/27/2004 | US6682897 Peptides derived from human heat protein 60 for treatment of diabetes, compositions, methods and kits |
| 01/27/2004 | US6682896 Isolated polyclonal antibody having neutralizing binding affinity for said peptides; diagnostic or prognostic assay where patient receiving ifn-beta therapy can be assessed for production of ifn-beta neutralizing antibodies |
| 01/27/2004 | US6682753 Increasing the effective concentration of a gpe- related compound (glycyl-prolyl-glutamic acid) in the central nervous system of the mammal to promote weight gain having condition that leads to decrease weight gain or weight loss |
| 01/27/2004 | US6682741 Vaccination and tumor therapy |
| 01/27/2004 | US6682740 Peptides derived fram complement peptide C3a sequence and antiallergic compositions comprising them |
| 01/27/2004 | US6682739 Methods of inhibiting osteoclastogenesis |
| 01/27/2004 | US6682738 Inducing expansion or stress relaxation |
| 01/27/2004 | US6682737 Monoclonal antibody having the same or overlapping epitope binding specificity as that of 3e2 secreted by hybridoma atcc hb 12075 |
| 01/27/2004 | US6682735 Anti-IgE antibodies |
| 01/27/2004 | US6682734 Anti-cd20 derived from transfectoma having atcc deposit numbers 69119 and hbe 1388 respectively; depletion of peripheral blood b cells |
| 01/27/2004 | US6682732 Treatment of lesions |
| 01/27/2004 | US6682731 Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules |
| 01/27/2004 | US6682730 Transplants for myocardial scars |
| 01/27/2004 | US6682728 Efficient and selective adenoviral-mediated gene transfer into vascular neointima |
| 01/27/2004 | US6682520 Tissue volume reduction |
| 01/27/2004 | CA2140663C Compounds which inhibit hiv replication |
| 01/27/2004 | CA2105374C Method of producing sustained-release microcapsules |
| 01/27/2004 | CA2002607C Natural killer stimulatory factor |
| 01/22/2004 | WO2004008102A2 Liver tumor marker sequences |
| 01/22/2004 | WO2004007772A1 Antisense modulation of cellular inhibitor of apoptosis-2 expression |
| 01/22/2004 | WO2004007770A2 Method for diagnosis of intestinal-type gastric tumors |
| 01/22/2004 | WO2004007764A2 Chromosome 3, 5 and 11 genes involved in premature canities |
| 01/22/2004 | WO2004007746A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN |
| 01/22/2004 | WO2004007734A1 Her-2/neu dna vaccine having anti-cancer activity |
| 01/22/2004 | WO2004007728A1 Regulation of human tripeptidyl peptidase ii |
| 01/22/2004 | WO2004007725A1 Polypeptide of streptococcus pyogenes |
| 01/22/2004 | WO2004007723A2 Genes |
| 01/22/2004 | WO2004007721A1 Conjugate for double-stranded rna sequence releasing and methods thereof |
| 01/22/2004 | WO2004007720A2 Treatment of proliferative disorders |
| 01/22/2004 | WO2004007719A1 Use of sumo- and ubiquitin-modified pcna for detection and channeling of dna transaction pathways |
| 01/22/2004 | WO2004007718A2 Rna-interference by single-stranded rna molecules |
| 01/22/2004 | WO2004007714A1 Human prothrombin analog and human meizothrombin analog |
| 01/22/2004 | WO2004007711A1 Novel proteins and use thereof |
| 01/22/2004 | WO2004007707A1 Process for producing a virus-inactivated thrombin preparation |
| 01/22/2004 | WO2004007695A2 Lactobacilli expressing biologically active polypeptides and uses thereof |
| 01/22/2004 | WO2004007693A2 Human immunosuppressive protein |
| 01/22/2004 | WO2004007689A2 Regulatory protein for nox enzymes |
| 01/22/2004 | WO2004007682A2 Methods and compositions for modulating t helper (th) cell development and function |
| 01/22/2004 | WO2004007679A2 Dendritic cell pontentiation |
| 01/22/2004 | WO2004007675A2 Neuronal and optic nerve gene expression patterns |
| 01/22/2004 | WO2004007674A2 Neuronal and retinal gene expression patterns |
| 01/22/2004 | WO2004007673A2 Neuronal gene expression patterns |
| 01/22/2004 | WO2004007671A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A CLLD8 PROTEIN |
| 01/22/2004 | WO2004007667A2 Polynucleotide and polypeptide fat metabolism regulators and uses thereof |
| 01/22/2004 | WO2004007557A2 Tf antagonist |
| 01/22/2004 | WO2004007552A1 Cytokine receptor |
| 01/22/2004 | WO2004007546A1 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases |
| 01/22/2004 | WO2004007544A2 Components of the presenilin-complex |
| 01/22/2004 | WO2004007543A1 Altered insulin-like growth factor binding proteins |
| 01/22/2004 | WO2004007540A1 Klebsiella membrane extracts exhibiting advantageous properties, and method for producing said extracts |
| 01/22/2004 | WO2004007537A2 Modified adenoviral fiber with ablated to cellular receptors |
| 01/22/2004 | WO2004007536A2 Interactions of the epstein-barr virus protein ebna1, and uses thereof |
| 01/22/2004 | WO2004007535A1 Bicyclic oligopeptides and their use as glucagon receptor antagonists |